{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:22:45Z","timestamp":1784874165432,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Netherlands Ministry of Health Welfare and Sport","doi-asserted-by":"publisher","award":["324366"],"award-info":[{"award-number":["324366"]}],"id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Developmental Disabilities"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ridd.2024.104824","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T13:25:52Z","timestamp":1724419552000},"page":"104824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Challenging behaviour, the application of restrictive measures and psychotropic drug prescription in people with intellectual disabilities"],"prefix":"10.1016","volume":"153","author":[{"given":"Josien","family":"Jonker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sytse Ulbe","family":"Zuidema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerda Margaretha","family":"de Kuijper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ridd.2024.104824_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12888-022-04479-w","article-title":"Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic review","volume":"23","author":"Adams","year":"2023","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1016\/j.ridd.2024.104824_bib2","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"American Journal of Mental Deficiency"},{"issue":"5","key":"10.1016\/j.ridd.2024.104824_bib3","first-page":"492","article-title":"Psychometric characteristics of the aberrant behavior checklist","volume":"89","author":"Aman","year":"1985","journal-title":"American Journal of Mental Deficiency"},{"key":"10.1016\/j.ridd.2024.104824_bib4","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA. https:\/\/doi.org\/10.1176\/appi.books.9780890425596.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"1","key":"10.1016\/j.ridd.2024.104824_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjc.12118","article-title":"Challenging behaviours in adults with an intellectual disability: A total population study and exploration of risk indices","volume":"56","author":"Bowring","year":"2017","journal-title":"British Journal of Clinical Psychology"},{"issue":"6","key":"10.1016\/j.ridd.2024.104824_bib6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/jir.12359","article-title":"Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study","volume":"61","author":"Bowring","year":"2017","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2024.104824_bib7","series-title":"The statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ridd.2024.104824_bib8","first-page":"120","article-title":"The Brief Symptom Inventory (BSI): Reliability and validity of a practical alternative to SCL-90","volume":"61","author":"de Beurs","year":"2006","journal-title":"Maandblad Geestelijke Volksgezondheid"},{"issue":"7","key":"10.1016\/j.ridd.2024.104824_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2788.2010.01275.x","article-title":"Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: Prevalence and reasons for prescription","volume":"54","author":"de Kuijper","year":"2010","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2024.104824_bib10","series-title":"NeuroPsychopharmacotherapy. Springer Nature, Switzerland AG","article-title":"Antipsychotic drug prescription and behavioral problems in individuals with intellectual disability","author":"de Kuijper","year":"2021"},{"issue":"24","key":"10.1016\/j.ridd.2024.104824_bib11","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.3390\/ijerph192417095","article-title":"Withdrawing antipsychotics for challenging behaviours in adults with intellectual disabilities; Experiences and views of prescribers","volume":"19","author":"de Kuijper","year":"2022","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"1","key":"10.1016\/j.ridd.2024.104824_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jir.12119","article-title":"Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour","volume":"59","author":"Deb","year":"2015","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2024.104824_bib13","unstructured":"Derogatis, L.R. (1975). Brief Symptom Inventory. Clinical Psychometric Research, Baltimore, MD."},{"issue":"3","key":"10.1016\/j.ridd.2024.104824_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ridd.2014.01.003","article-title":"Psychometric properties of a Dutch version of the Behavior Problems Inventory-01 (BPI-01)","volume":"35","author":"Dumont","year":"2014","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2024.104824_bib15","first-page":"2","article-title":"Multidisciplinaire richtlijn \u2018Probleemgedrag bij volwassenen met een verstandelijke beperking\u2019","volume":"1","author":"Embregts","year":"2020","journal-title":"NTZ: Nederlands Tijdschrift Voor D\u00e9lel\u0151tt Zorg Aan Mensen Met Verstandelijke Beperkingen"},{"issue":"1","key":"10.1016\/j.ridd.2024.104824_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0891-4222(00)00061-5","article-title":"The prevalence of challenging behaviors: A total population study","volume":"22","author":"Emerson","year":"2001","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2024.104824_bib17","unstructured":"Farmacotherapeutisch Kompas. Retrieved from https:\/\/www.farmacotherapeutischkompas.nl."},{"issue":"3-4","key":"10.1016\/j.ridd.2024.104824_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/19315864.2019.1630872","article-title":"Psychometric properties of the Norwegian aberrant behavior checklist and diagnostic relationships in a neuro-pediatric sample","volume":"12","author":"Halvorson","year":"2019","journal-title":"Journal of Mental Health Research in Intellectual Disabilities"},{"issue":"4","key":"10.1016\/j.ridd.2024.104824_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ridd.2005.06.001","article-title":"A total population study of challenging behaviour in the county of Hedmark, Norway: Prevalence, and risk markers","volume":"27","author":"Holden","year":"2006","journal-title":"Research in Developmental Disabilities"},{"issue":"9","key":"10.1016\/j.ridd.2024.104824_bib20","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/NMD.0b013e318183f85c","article-title":"Prevalence of, and factors associated with, problem behaviors in adults with intellectual disabilities","volume":"196","author":"Jones","year":"2008","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"4","key":"10.1016\/j.ridd.2024.104824_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cpp.410","article-title":"The factor structure of the brief symptom inventory: Intellectual disability evidence","volume":"11","author":"Kellett","year":"2004","journal-title":"Clinical Psychology & Psychotherapy"},{"issue":"2","key":"10.1016\/j.ridd.2024.104824_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jir.12800","article-title":"Exposure to challenging behaviours and burnout symptoms among care staff: The role of psychological resources","volume":"65","author":"Klaver","year":"2021","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2024.104824_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ridd.2015.07.022","article-title":"Proxy and self-reported quality of life in adults with intellectual disabilities: Impact of psychiatric symptoms, challenging behaviour, psychotropic medication and unmet needs","volume":"45-46","author":"Koch","year":"2015","journal-title":"Research in Developmental Disabilities"},{"issue":"4","key":"10.1016\/j.ridd.2024.104824_bib24","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.ridd.2013.01.010","article-title":"Prevalence and risk markers of behavior problems among adults with intellectual disabilities: A total population study in Orebro County, Sweden","volume":"34","author":"Lundqvist","year":"2013","journal-title":"Research in Developmental Disabilities"},{"issue":"2","key":"10.1016\/j.ridd.2024.104824_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1468-3148.2008.00483.x","article-title":"Frequency of use and characteristics of people with intellectual disabilities subject to physical interventions","volume":"22","author":"McGill","year":"2009","journal-title":"Journal of Applied Research in Intellectual Disabilities"},{"issue":"6","key":"10.1016\/j.ridd.2024.104824_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ridd.2004.03.001","article-title":"Pharmacological management of challenging behaviour of individuals with intellectual disability.","volume":"25","author":"McGillivray","year":"2004","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2024.104824_bib27","unstructured":"National Institute for Health and Care Excellence (2015). Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges. (No. NICE Guideline (NG11)). National Collaborating Centre for Mental Health, London, UK. Retrieved from \u3008https:\/\/www.nice.org.uk\/guidance\/ng11\u3009."},{"issue":"2","key":"10.1016\/j.ridd.2024.104824_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/jir.12471","article-title":"Problem behaviours and psychotropic medication use in intellectual disability: A multinational cross-sectional survey","volume":"62","author":"Perry","year":"2018","journal-title":"Journal of Intellectual Disability Research"},{"issue":"6","key":"10.1016\/j.ridd.2024.104824_bib29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ridd.2010.07.017","article-title":"Frequency and severity of challenging behaviour in people with profound intellectual and multiple disabilities","volume":"31","author":"Poppes","year":"2010","journal-title":"Research in Developmental Disabilities"},{"issue":"12","key":"10.1016\/j.ridd.2024.104824_bib30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/jir.12299","article-title":"Relabelling behaviour. The effects of psycho-education on the perceived severity and causes of challenging behaviour in people with profound intellectual and multiple disabilities","volume":"60","author":"Poppes","year":"2016","journal-title":"Journal of Intellectual Disability Research"},{"issue":"6","key":"10.1016\/j.ridd.2024.104824_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/jir.12268","article-title":"Risk factors associated with challenging behaviour in people with profound intellectual and multiple disabilities","volume":"60","author":"Poppes","year":"2016","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2024.104824_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ridd.2018.02.011","article-title":"Health-related quality of life in people with intellectual disability who use long-term antipsychotic drugs for challenging behaviour","volume":"75","author":"Ramerman","year":"2018","journal-title":"Research in Developmental Disabilities"},{"issue":"6","key":"10.1016\/j.ridd.2024.104824_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1023\/A:1013299028321","article-title":"The behavior problems inventory: An instrument for the assessment of self-injury, stereotyped behavior, and aggression\/destruction in individuals with developmental disabilities","volume":"31","author":"Rojahn","year":"2001","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"5","key":"10.1016\/j.ridd.2024.104824_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2788.2011.01506.x","article-title":"The Behavior Problems Inventory-Short Form for individuals with intellectual disabilities: part II: Reliability and validity","volume":"56","author":"Rojahn","year":"2012","journal-title":"Journal of Intellectual Disability Research"},{"issue":"2","key":"10.1016\/j.ridd.2024.104824_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1741-1130.2012.00345.x","article-title":"Restriction on restraints in the care for people with intellectual disabilities in the Netherlands: Lessons learned from Australia, UK, and United States","volume":"9","author":"Romijn","year":"2012","journal-title":"Journal of Policy and Practice in Intellectual Disabilities"},{"issue":"10","key":"10.1016\/j.ridd.2024.104824_bib36","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1016\/j.ridd.2013.06.009","article-title":"Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability","volume":"34","author":"Scheifes","year":"2013","journal-title":"Research in Developmental Disabilities"},{"key":"10.1016\/j.ridd.2024.104824_bib37","series-title":"Department of Clinical Child and Family Studies","article-title":"Reduction of coercive measures. A multidisciplinary approach in care for people with intellectual disabilities (Doctoral dissertation). Vrije Universiteit Amsterdam","author":"Schippers","year":"2019"},{"issue":"6","key":"10.1016\/j.ridd.2024.104824_bib38","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/jar.12635","article-title":"A structured programme to withdraw antipsychotics among adults with intellectual disabilities: The Cornwall experience","volume":"32","author":"Shankar","year":"2019","journal-title":"Journal of Applied Research in Intellectual Disabilities"},{"key":"10.1016\/j.ridd.2024.104824_bib39","first-page":"h4326","article-title":"Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study","volume":"351","author":"Sheehan","year":"2015","journal-title":"BMJ (Clinical Research\u00a0Edition)"},{"issue":"3","key":"10.1016\/j.ridd.2024.104824_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2215-0366(16)30191-2","article-title":"Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: A systematic review","volume":"4","author":"Sheehan","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ridd.2024.104824_bib41","unstructured":"Vilans. (2020). Stappenplan wet zorg en dwang. Retrieved from: \u3008https:\/\/www.vilans.nl\/kennis\/stappenplan-wet-zorg-en-dwang\u3009."},{"key":"10.1016\/j.ridd.2024.104824_bib42","unstructured":"Wet zorg en dwang [Care and Coercion Act] (2020)."},{"issue":"9","key":"10.1016\/j.ridd.2024.104824_bib43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2788.2011.01440.x","article-title":"Utility of the Brief Symptom Inventory (BSI) in psychiatric outpatients with intellectual disabilities","volume":"56","author":"Wieland","year":"2012","journal-title":"Journal of Intellectual Disability Research"},{"issue":"6","key":"10.1016\/j.ridd.2024.104824_bib44","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.ridd.2011.07.017","article-title":"Psychometric properties and norms of the German ABC-Community and PAS-ADD checklist","volume":"32","author":"Zeilinger","year":"2011","journal-title":"Research in Developmental Disabilities"}],"container-title":["Research in Developmental Disabilities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422224001562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422224001562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T21:53:58Z","timestamp":1725832438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891422224001562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":44,"alternative-id":["S0891422224001562"],"URL":"https:\/\/doi.org\/10.1016\/j.ridd.2024.104824","relation":{},"ISSN":["0891-4222"],"issn-type":[{"value":"0891-4222","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenging behaviour, the application of restrictive measures and psychotropic drug prescription in people with intellectual disabilities","name":"articletitle","label":"Article Title"},{"value":"Research in Developmental Disabilities","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ridd.2024.104824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104824"}}